The inhibition of PERK with a specific GSK inhibitor synergized with 5-FU resulted in suppressed tumor growth in mice, thereby we can conclude that the silencing of the PERK-ATF4 branch of the UPR signaling pathway greatly sensitizes CRC cells to 5-FU. This evidence concerns the gene ATF4 and neoplasm.